A Global health Partnership's use of time-limited support to catalyze health practice change: The case of GAVI's Injection safety support

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Levin, Ann ^a   Fang, Arnold ^b   Hansen, Peter M ^b   Pyle, David ^a   Dia, Ousmane ^a   Schwalbe, Nina ^b  

^a GAVI Alliance ^*  (United States)

^b JOHN SNOW INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTO DISABLE SYRINGE; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; GLOBAL ALLIANCE OF VACCINES AND IMMUNIZATION; HEALTH PROGRAM; IMMUNIZATION; MEDICAL DECISION MAKING; MEDICAL PRACTICE; POLITICAL PARTICIPATION; PUBLIC-PRIVATE PARTNERSHIP; SAFETY; SOCIOECONOMICS; SOLID WASTE MANAGEMENT; SYRINGE; ECONOMICS; HEALTH; HUMAN; INJECTION; INSTRUMENTATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE;

VACCINE;

FINANCING, GOVERNMENT; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INJECTIONS; SAFETY; SYRINGES; VACCINES; WORLD HEALTH;

EID: 77958541043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012986     Document Type: Article

References (10)

1. Pearson M (2004) Economic and financial aspects of the global health partnership. Paper No. 2, DFID Study - Global Health Partnerships: assessing the impact.
2. Ravishankar N, Gubbins P, Cooley R, Leach-Kemon K, Michaud C, et al. (2009) Financing of global health: tracking development assistance for health from 1990 to 2007. The Lancet 373: 2113-2124.
3. World Health Organization Maximizing Positive Synergies Collaborative Group (2009) An assessment of interactions between global health initiatives and country health systems. The Lancet 373: 2137-2169.
4. Caines K (2004) Health Partnerships and Neglected Diseases. Paper No. 4, DFID Study - Global Health Partnerships: assessing the impact.
5. Dziekan G (2003) The cost-effectiveness of policies for the safe and appropriate use of injection in health care settings. Bulletin of the World Health Organization, Vol. 81, no. 4, Genebra.
6. Miller M, Pisani E (1999) The cost of unsafe injections. Bulletin of the World Health Organization 77: 808-811.
7. Ahmedov M, Azimov R, Alimova V, Rechel B (2008) Health Systems in Transition: HiT profile in brief. Uzbekistan. Copenhagen, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies.
8. Battersby A, Feilden R, Nelson, C (1999a) Sterilizable syringes: excessive risk or cost-effective option. Bulletin of the World Health Organization 77: 812-818.
9. Battersby A, Feilden R, Stoeckel P, Da Silva A, Nelson C, et al. (1999b) Strategies for safe injections. Bulletin of the World Health Organization 77: 996-1000.
10. WHO Injection Safety, Fact sheet Nu231, Revised October 2006.